Principal Display Panel
Label (Kynamro Label)
Kynamro
FDA Label NDC 70688-0502
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Kastle Therapeutics, Llc for the product Kynamro (NDC 70688-0502). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
* Please review the disclaimer below.
